[HTML][HTML] GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update

PJ Hoskin, A Colombo, A Henry, P Niehoff… - Radiotherapy and …, 2013 - Elsevier
Background: HDR afterloading brachytherapy (HDRBT) for prostate cancer is now
established as an effective technique to achieve dose escalation in the radical treatment of …

The evolution of brachytherapy for prostate cancer

NG Zaorsky, BJ Davis, PL Nguyen… - Nature Reviews …, 2017 - nature.com
Abstract Brachytherapy (BT), using low-dose-rate (LDR) permanent seed implantation or
high-dose-rate (HDR) temporary source implantation, is an acceptable treatment option for …

EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer

P Cornford, J Bellmunt, M Bolla, E Briers, M De Santis… - European urology, 2017 - Elsevier
Objective To present a summary of the 2016 version of the European Association of Urology
(EAU)–European Society for Radiotherapy & Oncology (ESTRO)–International Society of …

American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy

Y Yamada, L Rogers, DJ Demanes, G Morton… - Brachytherapy, 2012 - Elsevier
PURPOSE: A well-established body of literature supports the use of high-dose-rate (HDR)
brachytherapy as definitive treatment for localized prostate cancer. Most of the articles …

Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy

MA Haider, P Chung, J Sweet, A Toi, K Jhaveri… - International Journal of …, 2008 - Elsevier
PURPOSE: To compare the performance of T2-weighted (T2w) imaging and dynamic
contrast-enhanced (DCE) magnetic resonance imaging (MRI) of the prostate gland in the …

Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate‐specific antigen failure: a systematic review of the literature

PL Nguyen, AV D'Amico, AK Lee… - … International Journal of …, 2007 - Wiley Online Library
Among men who experience prostate‐specific antigen (PSA) failure after external beam
radiation or brachytherapy (RT), many will harbor occult micrometastases; however, a …

Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes

CP Chen, V Weinberg, K Shinohara, M Roach III… - International Journal of …, 2013 - Elsevier
PURPOSE: Evaluate efficacy and toxicity of salvage high-dose-rate brachytherapy (HDRB)
for locally recurrent prostate cancer after definitive radiation therapy (RT). METHODS AND …

Self-assembling nanoparticles for intra-articular delivery of anti-inflammatory proteins

RE Whitmire, DS Wilson, A Singh, ME Levenston… - Biomaterials, 2012 - Elsevier
Intra-articular delivery of therapeutics to modulate osteoarthritis (OA) is challenging. Delivery
of interleukin-1 receptor antagonist (IL-1Ra), the natural protein inhibitor of IL-1, to modulate …

[HTML][HTML] A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy

Y Yamada, MA Kollmeier, X Pei, CC Kan, NC Gil'ad… - Brachytherapy, 2014 - Elsevier
Purpose We report the toxicity and biochemical tumor control outcome of a prospective
Phase II study using high-dose-rate brachytherapy (HDR) alone as a salvage therapy for …

[HTML][HTML] High-dose-rate brachytherapy as monotherapy for prostate cancer

DJ Demanes, MI Ghilezan - Brachytherapy, 2014 - Elsevier
Purpose To review and analyze the published data on high-dose-rate brachytherapy as
monotherapy in the treatment of prostate cancer. Methods A literature search and a …